MedTrace Logo

Positive Airway Pressure Therapy Study in Sleep Apnea and Diastolic Heart Failure

NCT02254382 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-04-17

No results posted yet for this study

Summary

This is a multicenter, prospective, randomized clinical trial (pilot study). 20 participants with diastolic heart failure will be assigned to ventilation therapy (AutoSet CS ™ ASV device; therapy group). The trial will run for 6 months, after which change in echocardiographic parameters of diastolic left ventricular function, sleep and quality of life parameters will be evaluated.

Conditions

  • Diastolic Heart Failure

Interventions

DEVICE

Adaptive servo ventilation (ASV)

Non-invasive Ventilation used to control central and obstructive sleep apnea.

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Olaf Oldenburg, MD · Herz- und Diabeteszentrum NRW, Bad Oeynhausen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02254382 on ClinicalTrials.gov